Loading...
XSHG603939
Market cap3.86bUSD
Jan 17, Last price  
23.38CNY
1D
0.78%
1Q
3.54%
Jan 2017
-21.12%
IPO
51.62%
Name

Yifeng Pharmacy Chain Co Ltd

Chart & Performance

D1W1MN
XSHG:603939 chart
P/E
20.04
P/S
1.25
EPS
1.17
Div Yield, %
1.02%
Shrs. gr., 5y
5.46%
Rev. gr., 5y
26.72%
Revenues
22.59b
+13.59%
1,224,107,7371,539,478,4301,804,299,3442,230,225,6502,845,515,8553,733,619,1354,807,249,0086,912,576,54210,276,174,73413,144,502,41515,326,305,26619,886,395,83522,588,227,402
Net income
1.41b
+11.90%
55,878,82068,603,71999,187,742140,561,204175,935,962223,891,074313,503,561416,414,103543,750,303743,522,732887,884,4971,261,841,0391,411,985,024
CFO
4.66b
+18.95%
080,726,610156,708,014212,345,071181,517,411139,937,791317,202,120510,711,302963,234,2341,335,655,4872,149,969,9723,920,267,3044,663,259,413
Dividend
Jun 07, 20240.5 CNY/sh
Earnings
May 20, 2025

Profile

Yifeng Pharmacy Chain Co., Ltd. retails pharmaceutical products in China. As of March 31, 2021, it operates approximately 6,279 pharmaceutical chain stores in Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The company was founded in 2001 and is based in Changsha, China.
IPO date
Feb 17, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
22,588,227
13.59%
19,886,396
29.75%
Cost of revenue
19,699,824
17,061,873
Unusual Expense (Income)
NOPBT
2,888,404
2,824,523
NOPBT Margin
12.79%
14.20%
Operating Taxes
456,663
450,292
Tax Rate
15.81%
15.94%
NOPAT
2,431,741
2,374,231
Net income
1,411,985
11.90%
1,261,841
42.12%
Dividends
(288,682)
(215,583)
Dividend yield
0.60%
0.47%
Proceeds from repurchase of equity
(3,521)
(1)
BB yield
0.01%
0.00%
Debt
Debt current
103,484
1,277,800
Long-term debt
4,544,638
4,130,821
Deferred revenue
54,094
54,690
Other long-term liabilities
4
1
Net debt
(1,141,473)
962,013
Cash flow
Cash from operating activities
4,663,259
3,920,267
CAPEX
(739,925)
Cash from investing activities
(3,011,635)
Cash from financing activities
(2,101,244)
FCF
1,658,668
1,986,636
Balance
Cash
5,196,627
4,162,564
Long term investments
592,969
284,044
Excess cash
4,660,184
3,452,288
Stockholders' equity
6,427,479
5,130,112
Invested Capital
8,283,610
8,897,985
ROIC
28.31%
26.95%
ROCE
22.27%
22.83%
EV
Common stock shares outstanding
1,209,999
1,006,735
Price
40.04
-12.19%
45.60
-17.26%
Market cap
48,448,369
5.54%
45,907,102
-16.90%
EV
47,949,551
47,434,503
EBITDA
4,720,194
4,265,624
EV/EBITDA
10.16
11.12
Interest
160,529
165,209
Interest/NOPBT
5.56%
5.85%